Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 500 participants.

Also called NCT02194608

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02194608
Other papers using this trial's data
  • A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes Diabetes technology & therapeutics, 2015-08 DOI, PubMed 26154338

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02194608. Randomized; no masking. Start 2011-12 (registry gives no type); primary completion 2013-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Home telehealth system
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct02194608
Content hash
6fc2d41695df4e1bc8e62a5bd911bbeb97cec6cae90281faa37c85c6772514f3